Literature DB >> 23723105

Portal hypertension related to light chain deposition disease of liver: an enlightening experience.

Arunansu Talukdar1, Kabita Mukherjee, Dibbendhu Khanra, Manjari Saha.   

Abstract

A 55-year-old alcoholic man presented with firm hepatomegaly, ascites and markedly elevated alkaline phosphatase. He had a history of pulmonary tuberculosis. Work-up for malignancy was negative. Histological examination of liver showed extracellular deposition of pink amorphous material which is Congo red stain negative. Deteriorating renal function and nephrotic-range proteinuria were noted. Renal histology showed thickening of the glomerular and tubular basement membranes by non-congophilic deposits along with mesangial expansion. Bone marrow examination revealed patchy areas of pink amorphous deposits which are Congo red stain negative. Immunohistochemical staining of amorphous depositions in liver, kidney and bone marrow were positive for κ light chains. Serum-free light chain assay confirmed markedly elevated free κ-light chain. κ-light chain deposition disease is a systemic disease with universal renal involvement but rarely it presents as chronic cholestatic liver disease with portal hypertension and frequently associated with fatal outcome due to diagnostic delay.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23723105      PMCID: PMC3669975          DOI: 10.1136/bcr-2013-009553

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

Review 1.  Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level.

Authors:  Pierre M Ronco; Marie-Alexandra Alyanakian; Beatrice Mougenot; Pierre Aucouturier
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

2.  Light chain deposition disease presenting as massive hepatomegaly.

Authors:  Shriram Vaidia Nath; Modisha Peiris; Mark J Bishton; Ellen Maxwell; H Miles Prince
Journal:  Pathology       Date:  2010-04       Impact factor: 5.306

3.  Cardiac nonamyloidotic immunoglobulin deposition disease.

Authors:  Amir A Toor; Ben A Ramdane; Jacob Joseph; Maria Thomas; Carl O'Hara; Bart Barlogie; Patrick Walker; Lija Joseph
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

4.  Induction treatment of light chain deposition disease with bortezomib: rapid hematological response with persistence of renal involvement.

Authors:  Jiri Minarik; Vlastimil Scudla; Tomas Tichy; Tomas Pika; Jaroslav Bacovsky; Pavel Lochman; Josef Zadrazil
Journal:  Leuk Lymphoma       Date:  2011-10-24

Review 5.  Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains.

Authors:  J L Preud'homme; P Aucouturier; G Touchard; L Striker; A A Khamlichi; A Rocca; L Denoroy; M Cogné
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612

6.  Glomerulopathic light chain-mesangial cell interactions modulate in vitro extracellular matrix remodeling and reproduce mesangiopathic findings documented in vivo.

Authors:  G A Herrera; W J Russell; J Isaac; E A Turbat-Herrera; Y M Tagouri; P W Sanders; M M Picken; S Dempsey
Journal:  Ultrastruct Pathol       Date:  1999 Mar-Apr       Impact factor: 1.094

7.  Renal monoclonal immunoglobulin deposition disease: the disease spectrum.

Authors:  Julie Lin; Glen S Markowitz; Anthony M Valeri; Neeraja Kambham; William H Sherman; Gerald B Appel; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

8.  Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation.

Authors:  K Weichman; L M Dember; T Prokaeva; D G Wright; K Quillen; M Rosenzweig; M Skinner; D C Seldin; V Sanchorawala
Journal:  Bone Marrow Transplant       Date:  2006-07-24       Impact factor: 5.483

Review 9.  Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.

Authors:  Claudio Pozzi; Marco D'Amico; Giovanni B Fogazzi; Simona Curioni; Franco Ferrario; Sonia Pasquali; Giacomo Quattrocchio; Cristiana Rollino; Siro Segagni; Francesco Locatelli
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

Review 10.  Kidney and liver involvement in monoclonal light chain disorders.

Authors:  Claudio Pozzi; Francesco Locatelli
Journal:  Semin Nephrol       Date:  2002-07       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.